Related Experiment Video
Updated: Jun 8, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Recent advances in management of cerebrovascular diseases
1Division of Neurology, University of Alberta Edmonton, Alberta T6G 2B7 Canada.
Insights
Managing vascular risk factors comprehensively lowers stroke risk for primary and secondary prevention. Key strategies include blood pressure control, statin use, anti-platelet therapy, and timely thrombolysis for acute stroke.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Background:
- Vascular risk factors significantly contribute to the incidence of both first-time and recurrent strokes.
- Effective management strategies are crucial for improving stroke outcomes and reducing long-term disability.
- Recent research has advanced our understanding of interventions for stroke prevention and treatment.
Purpose of the Study:
- To summarize current evidence on comprehensive management of vascular risk factors for stroke prevention.
- To highlight recent findings on blood pressure treatment, statin therapy, and anti-platelet agents.
- To review the efficacy of thrombolysis in acute stroke management.
Main Methods:
- Literature review of recent studies on vascular risk factor management.
- Analysis of clinical trial data on blood pressure, lipid-lowering, and anti-platelet therapies.
- Evaluation of evidence for thrombolysis in acute ischemic stroke.
Main Results:
- Comprehensive management of vascular risk factors reduces the risk of primary and secondary strokes.
- Blood pressure treatment benefits the elderly; statins are effective even in those with normal LDL levels.
- Comparative studies inform the choice of anti-platelet agents; thrombolysis shows efficacy beyond 3 hours for acute stroke.
Conclusions:
- A multifaceted approach to vascular risk factor management is essential for stroke prevention.
- Evidence supports interventions like blood pressure control, statins, and anti-platelet agents.
- Timely thrombolysis remains a critical treatment for acute ischemic stroke, with extended therapeutic windows being explored.
Abstract:
A comprehensive approach to managing the vascular risk factors in both primary and secondary stroke prevention settings can lower the risk of first and recurrent stroke. Recent studies highlight the benefits of blood pressure treatment in the elderly, use of statins in healthy subjects with normal low-density lipoprotein levels, and comparison of various anti-platelet agents. For acute stroke the efficacy of thrombolysis beyond 3 hours has recently been shown.
Related Concept Videos
Dementia l: Introduction
Atherosclerosis III: Management
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
